Phosducin-like protein 2 pseudogene 2 (PDCL2P2)

Phosducin-like protein 2 pseudogene 2 (PDCL2P2) is annotated as a human pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not code for active proteins due to mutations or disruptions in their coding sequence. While some pseudogenes may have regulatory roles at the RNA level—acting as competitive endogenous RNAs (ceRNAs), decoys for microRNAs, or sources of non-coding RNA fragments—there is no specific evidence in the scientific literature that PDCL2P2 encodes a functional RNA or peptide, or that it has established biological, pathological, or therapeutic relevance. Unlike its functional parental gene PDCL2, which is involved in spermatogenesis[1], PDCL2P2 has not been implicated in cellular signaling, disease pathology, or as a drug target. PDCL2P2 is not a protein-coding gene and is listed as a pseudogene with no protein product or known direct functions[1]. Pseudogenes in general can sometimes impact gene expression or disease progression via RNA-level regulation, but there is no evidence this applies specifically to PDCL2P2[2][5]. No drugs, mechanisms of action, biomarkers, or safety considerations are associated with PDCL2P2 due to its pseudogene status and lack of functional activity. There is nothing misspelled or conceptually wrong with the entry. However, PDCL2P2 is not a protein, receptor, or typical drug target but a genomically characterized pseudogene. It is not a canonical therapeutic or biomarker target[1][2][5].

Other names

PDCL2P2phosducin-like 2 pseudogene 2